Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wulffraat, N. M.
Right arrow Articles by Petty, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wulffraat, N. M.
Right arrow Articles by Petty, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 1999; 38: 777-778
© 1999 British Society for Rheumatology

Paediatric Rheumatology: Autologous Stem Cell Transplantation in Rheumatic Diseases of Childhood

Addendum: proposed guidelines for autologous stem cell transplantation in juvenile chronic arthritis

Series Editor: P. Woo

N. M. Wulffraat, W. Kuis and R. Petty1

Department of Paediatric Immunology and Rheumatology, University Hospital for Children `Het Wilhelmina Kinderziekenhuis', PO Box 85090, 3508 AB Utrecht, The Netherlands and
1 Division of Rheumatology, British Columbia Children's Hospital, Vancouver, Canada

Summary

In order to be eligible for autologous stem cell transplantation (ASCT), patients must fulfil the following criteria:

  1. The diagnosis must be certain according to ACR or EULAR criteria; disease course subtypes: systemic onset with polyarticular course or polyarticular onset.
  2. Duration of the disease at least 1 yr.
  3. There must be evidence of active inflammatory disease for at least the last 6 months.
  4. There must be evidence of unresponsiveness to, or toxicity from, standard therapy.
  5. The patient's general condition must be . . . [Full Text of this Article]

Diagnosis

Evaluation for ABMT

Current disease status juvenile chronic arthritis/juvenile rheumatoid arthritis

Transplantation

Conditioning regimen

Follow-up

The Registry for Juvenile Rheumatic Diseases and Bone Marrow Transplantation

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
H. Foster, J. Davidson, E. Baildam, M. Abinun, L. R. Wedderburn, and on behalf of the British Society for Paediatric an
Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: Guidance for BSPAR members--executive summary
Rheumatology, December 1, 2006; 45(12): 1570 - 1571.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
L R Wedderburn, M Abinun, P Palmer, and H E Foster
Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis
Arch. Dis. Child., March 1, 2003; 88(3): 201 - 205.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
L. R. Wedderburn, R. Jeffery, H. White, A. Patel, H. Varsani, D. Linch, K. Murray, and P. Woo
Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO+ to RA+ phenotype
Rheumatology, November 1, 2001; 40(11): 1299 - 1307.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
W. Kuis, N. M. Wulffraat, and R. E. Petty
Autologous stem cell transplantation: an alternative for refractory juvenile chronic arthritis
Rheumatology, August 1, 1999; 38(8): 737 - 738.
[Full Text] [PDF]